30
Participants
Start Date
October 30, 2019
Primary Completion Date
February 24, 2020
Study Completion Date
November 9, 2020
RHA® Redensity with new anesthetic agent
A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus zooepidemicus, formulated to a concentration of 15 mg/g and 0.3% w/w of new anesthetic agent in a physiologic buffer.
RHA® Redensity with lidocaine
A sterile, biodegradable, biocompatible, viscoelastic, clear, colorless, homogenized gel implant. It consists of cross-linked hyaluronic acid produced by fermentation of Streptococcus zooepidemicus, formulated to a concentration of 15 mg/g and 0.3% w/w lidocaine in a physiologic buffer.
Florida, Coral Gables
Chicago, Chicago
California, Beverly Hills
Teoxane SA
INDUSTRY